WAI bio
Healthcare AI
Diagnostics (breast implant imaging and complication detection)
Seed
WAI bio is a private South Korea–based healthtech startup that develops **AI-driven breast implant diagnostic software** for plastic and reconstructive surgery. Its core product uses ultrasound images and videos plus multiple AI algorithms to identify different implant types and detect complications such as ruptures and capsular contracture, aiming to improve safety and diagnostic accuracy for breast augmentation and reconstruction patients in clinical practice.
Company Details
- Website
- w-ai.ai
- Headquarters
- Seoul, South Korea
- Founded
- 2023
- Funding
- $233K
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring